Annie Lowrey has a smart piece in the NYT Magazine about how the cannabis business is likely to look after legalization. She gets one key point – much lower prices – though she doesn’t develop its implications for the size of the cannabis market and the prevalence cannabis abuse disorder; that’s not what her story is about.
The focus of the article is on consistency, and how the industry is stumbling toward being able to deliver a reproducible product, to the point where two joints with the same brand name will be alike as two beers with the same brand name. If that happens – and I think Lowrey is right that it will – that might make cannabis a much safer product. But there’s a subtlety here.